Roche Holding reported CHF10.98 in EPS Earnings Per Share for its fiscal semester ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2025H2 Dec/2025 8.37 10.35 2.80 Jan/29
FY2025H1 Jun/2025 9.23 10.8 12682000000.0000 Jul/22
FY2024H2 Dec/2024 2.80 8.25 Jan/29
FY2024H1 Jun/2024 7.80 12353000000.0000 Jul/21
FY2023H2 Dec/2023 8.25 8.37 10432000000.0000 Feb/01




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Alcon AG USD 0.91 0.07 Sep/2026
Almirall EUR 0.2 0.13 Jun/2026
Amgen USD 6.45 0.16 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Fresenius EUR 0.86 0.03 Sep/2026
Fresenius Medical Care EUR 1.11 0.01 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
GRIFOLS EUR 0.3 0.07 Sep/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.23 0.03 Sep/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.04 2.58 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Orion EUR 1.19 0.19 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Philips EUR 0.35 0.14 Sep/2026
Recordati EUR 0.66 0.01 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
UCB EUR 5.65 3.21 Dec/2025